The pathophysiology of levodopa-induced dyskinesias (LID) in Parkinson’s disease is not well understood. We have recorded local field potentials (LFP) from macroelectrodes implanted in the subthalamic nucleus (STN) of 14 patients with Parkinson’s disease following surgical treatment with deep brain stimulation. Patients were studied in the ‘Off’ medication state and in the ‘On’ motor state after administration of levodopa– carbidopa (po) or apomorphine (sc) that elicited dyskinesias in 11 patients. The logarithm of the power spectrum of the LFP in selected frequency bands (4–10, 11–30 and 60–80 Hz) was compared between the ‘Off’ and ‘On’ medication states. A peak in the 11–30 Hz band was recorded in the ‘Off’ medication state and red...
Parkinson‘s disease (PD) is a progressive and disabling neurodegenerative disease, characterized by ...
Exaggerated bursts of activity at frequencies in the low beta band are a well-established phenomenon...
Deep-brain stimulation of the subthalamic nucleus appears to reduce levodopa-induced dyskinesias, bu...
The pathophysiology of levodopa-induced dyskinesias (LID) in Parkinson’s disease is not well underst...
The pathophysiology of levodopa-induced dyskinesias (LID) in Parkinson’s disease is not well underst...
Background Levodopa is the most efficacious drug in the symptomatic therapy of motor symptoms in Pa...
Dyskinetic disorders are characterized by excess of motor activity that may interfere with normal mo...
Levodopa‐induced dyskinesia is a common complication in Parkinson disease. Pathogenic mechanisms inc...
Panagiotis Bargiotas, Spyridon KonitsiotisDepartment of Neurology, University of Ioannina, Ioannina,...
Levodopa is the first-line treatment for Parkinson’s disease, although the precise mechanisms mediat...
Parkinson’s disease (PD) is primarily a motor disorder that involves the gradual loss of motor funct...
Parkinson’s disease (PD) is a neurodegenerative disease, in which the progressive loss of dopamine n...
fter its first use in clinic since 1960, oral administration of l-3,4-dihydroxyphenylalanine (levodo...
Severe dyskinesias or ballism can occur following hemorrhagic events in the subthalamic nucleus (STN...
Levodopa-induced dyskinesia is a major complication of long-term dopamine replacement therapy for Pa...
Parkinson‘s disease (PD) is a progressive and disabling neurodegenerative disease, characterized by ...
Exaggerated bursts of activity at frequencies in the low beta band are a well-established phenomenon...
Deep-brain stimulation of the subthalamic nucleus appears to reduce levodopa-induced dyskinesias, bu...
The pathophysiology of levodopa-induced dyskinesias (LID) in Parkinson’s disease is not well underst...
The pathophysiology of levodopa-induced dyskinesias (LID) in Parkinson’s disease is not well underst...
Background Levodopa is the most efficacious drug in the symptomatic therapy of motor symptoms in Pa...
Dyskinetic disorders are characterized by excess of motor activity that may interfere with normal mo...
Levodopa‐induced dyskinesia is a common complication in Parkinson disease. Pathogenic mechanisms inc...
Panagiotis Bargiotas, Spyridon KonitsiotisDepartment of Neurology, University of Ioannina, Ioannina,...
Levodopa is the first-line treatment for Parkinson’s disease, although the precise mechanisms mediat...
Parkinson’s disease (PD) is primarily a motor disorder that involves the gradual loss of motor funct...
Parkinson’s disease (PD) is a neurodegenerative disease, in which the progressive loss of dopamine n...
fter its first use in clinic since 1960, oral administration of l-3,4-dihydroxyphenylalanine (levodo...
Severe dyskinesias or ballism can occur following hemorrhagic events in the subthalamic nucleus (STN...
Levodopa-induced dyskinesia is a major complication of long-term dopamine replacement therapy for Pa...
Parkinson‘s disease (PD) is a progressive and disabling neurodegenerative disease, characterized by ...
Exaggerated bursts of activity at frequencies in the low beta band are a well-established phenomenon...
Deep-brain stimulation of the subthalamic nucleus appears to reduce levodopa-induced dyskinesias, bu...